Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card!
Core Laboratories N.V. (NYSE:CLB) is a stock with outstanding fundamental characteristics. When we build an investment case, we need to look at the stock with a holistic perspective. In the case of CLB, it is a highly-regarded dividend payer that has been able to sustain great financial health over the past. Below is a brief commentary on these key aspects. If you're interested in understanding beyond my broad commentary, read the full report on Core Laboratories here.
Established dividend payer with adequate balance sheet
CLB is financially robust, with ample cash on hand and short-term investments to meet upcoming liabilities. This implies that CLB manages its cash and cost levels well, which is a crucial insight into the health of the company. CLB appears to have made good use of debt, producing operating cash levels of 0.39x total debt in the prior year. This is a strong indication that debt is reasonably met with cash generated.
Income investors would also be happy to know that CLB is one of the highest dividend payers in the market, with current dividend yield standing at 4.4%. CLB has also been regularly increasing its dividend payments to shareholders over the past decade.
For Core Laboratories, I've compiled three fundamental aspects you should further examine:
- Future Outlook: What are well-informed industry analysts predicting for CLB’s future growth? Take a look at our free research report of analyst consensus for CLB’s outlook.
- Historical Performance: What has CLB's returns been like over the past? Go into more detail in the past track record analysis and take a look at the free visual representations of our analysis for more clarity.
- Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of CLB? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!
We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
If you spot an error that warrants correction, please contact the editor at firstname.lastname@example.org. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.